The U.S. stock markets hit the jackpot in 2017, with all the major indexes up significantly — the S&P 500 gained 19% over the past year, the Dow Jones Industrial Average was up 25% and the tech-heavy Nasdaq was up an impressive 28% — making year-end assessments by investors a very happy occasion.
Amazingly, the U.S, markets ranked 39th out of 47 countries in 2017, making this past year a relative stinker compared to the rest of the world’s stocks.
Why the “down” year?
It’s possible that investors have figured out that U.S. stocks are overvalued relative to stocks in other countries. So, while U.S. markets underperformed on a comparable basis, it can always be worse, as Canada demonstrates.
In 2017, Canadian stocks gained just 6% on the year with energy companies providing a significant headwind to better performance. Here in the U.S., the major indexes are much less dependent on energy stocks, hence the higher returns.
Hot Canadian Stocks To Watch For 2019: Genomic Health, Inc.(GHDX)
Advisors’ Opinion:
- [By Stephan Byrd]
ELEKTA AB/ADR (OTCMKTS: EKTAY) and Genomic Health (NASDAQ:GHDX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.
- [By Stephan Byrd]
Genomic Health, Inc. (NASDAQ:GHDX) insider Kimberly J. Popovits sold 10,000 shares of Genomic Health stock in a transaction on Thursday, June 14th. The shares were sold at an average price of $48.89, for a total value of $488,900.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
- [By Shane Hupp]
Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.
- [By Logan Wallace]
Carillon Tower Advisers Inc. bought a new position in shares of Genomic Health (NASDAQ:GHDX) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 75,375 shares of the medical research company’s stock, valued at approximately $2,358,000.
Hot Canadian Stocks To Watch For 2019: Kura Oncology, Inc.(KURA)
Advisors’ Opinion:
- [By Shane Hupp]
Kura Oncology (NASDAQ:KURA) was the target of unusually large options trading on Thursday. Stock investors bought 699 put options on the company. This represents an increase of 694% compared to the typical daily volume of 88 put options.
Hot Canadian Stocks To Watch For 2019: Landec Corporation(LNDC)
Advisors’ Opinion:
- [By Shane Hupp]
Get a free copy of the Zacks research report on Landec (LNDC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
